Global Basal cell Carcinoma Therapeutics Market 2018-2022
About this market
The advancements in the field of oncology research is expected to help the market grow during the forecast period. The key players in the market are constantly developing medicines for various cancer indications. Technavio’s analysts have predicted that the basal cell carcinoma therapeutics market will register a CAGR of around 6% by 2022.
Heavy investments to develop a strong R&D department
The market is expected to be driven by the heavy investments incurred to develop a strong R&D department for basal cell carcinoma treatment. Cancer is considered one of the most common causes of death across the globe, and the prevalence of cancer has witnessed a rapid surge in the past few years.
Higher demand for the surgical treatments for basal cell carcinoma
One of the major challenges faced by the global basal cell carcinoma therapeutics market is the availability of non-therapeutic treatment options such as surgeries.
For the detailed list of factors that will drive and challenge the growth of the basal cell carcinoma therapeutics market during the 2019-2023, view our report.
The market appears to be concentrated and with the presence of few vendors including Bausch Health and Biofrontera the competitive environment is quite intense. Factors such as the advancements in the field of oncology research and heavy investments to develop a strong R&D department, will provide considerable growth opportunities to basal cell carcinoma therapeutics manufactures. Bausch Health, Biofrontera, Mylan, Sun Pharmaceutical, and F. Hoffmann-La Roche are some of the major companies covered in this report.
‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities. Some of the established pharmaceutical companies and various government organizations are investing profoundly in the R&D of novel therapies, which is currently dominated by biologic molecules due to their high effectiveness.’
Technavio Announces the Publication of its Research Report – Global Basal Cell Carcinoma Therapeutics Market 2019-2023
Technavio recognizes the following companies as the key players in the global basal cell carcinoma therapeutics market: Bausch Health, Biofrontera, Mylan, Sun Pharmaceutical, and F. Hoffmann-La Roche.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the advancements in the field of oncology research.”
According to the report, one of the major drivers for this market is the Heavy investments to develop a strong R&D department.
Further, the report states that one of the major factors hindering the growth of this market is the higher demand for the surgical treatments for basal cell carcinoma.
F. Hoffmann-La Roche
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook